Susan Gawel

Title: The Innovations of Susan Gawel

Introduction

Susan Gawel is an accomplished inventor based in LaGrange Park, Illinois. She has made significant contributions to the field of medical science, particularly in the treatment of insulin resistance. Her innovative work has the potential to impact many individuals experiencing prolonged physical inactivity.

Latest Patents

Susan Gawel holds a patent for a method related to the treatment of insulin resistance associated with prolonged physical inactivity. This patent includes insulin resistance biomarkers and methods for utilizing these biomarkers. The biomarkers may consist of blood biomarkers such as C-peptide, Insulin-Like Growth Factor-Binding Protein 2 (IGFBP-2), and Leptin. Additionally, her patent outlines a method for reducing the effects of prolonged physical inactivity on insulin resistance in individuals who are experiencing or are expected to experience such inactivity.

Career Highlights

Gawel is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to focus on innovative solutions that address critical health issues. With her expertise, she has contributed to advancements in medical research and treatment methodologies.

Collaborations

Throughout her career, Susan has collaborated with notable colleagues, including Menghua Luo and Suzette Pereira. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.

Conclusion

Susan Gawel's contributions to the treatment of insulin resistance highlight her role as a significant inventor in the healthcare industry. Her innovative approaches and collaborations continue to pave the way for advancements in medical science.